Drug Discovery and Traditional Chinese Medicine: Science, Regulation, and Globalization 2001 edition

Marc Notes: Includes bibliographical references and index. Table of Contents: Preface. Acknowledgements. 1. Approaching Traditional Chinese Medicine: Inheritance and Exploration; Yongzheng Hui. 2. Floras, Plant Conservation and China's Future; P. H. Raven. 3. Natural Products Drug Discovery and Development at the United States National Cancer Institute; G. M. Cragg, D. J. Newman. 4. The Global Importance of Plants as Source of Medicines and the Future Potential of Chinese Plants; J. Miller. 5. Food, Medicinal Plants and Other Edible Materials as Sources of Bioactive Compounds that Enhance Metabolic Fitness and Improve Health; S. C. Bobzin, P. Burn. 6. Regions in China Rich in Resource for Medicinal Plants. A. Anhui Province; Zuojun Jiang. B. Hubie Province; Lincheng Ma. 7. The Camtothecin Expience: From Chinese Medicinal Plants to Potent Anti-Cancer Drugs; S. S. Yang, et al. 8. Approaches for Evaluation Immune-Modulation and Anti-Tumor Bioactivities in Chinese Medical Herbal Extracts; Pei-Fen Su, et al. 9. Using Transcription Factor Based Assays to Study Herbal Products; D. Pasco. 10. Molecular Basis for Medicinal Actions of Androgens and Green Tea Epigallocatechin Gallate; Shutsung Liao, et al. 11. Studies on Chemical Components and the Pharmacological Activity of Panax Ginseng Root; Li-Xiangao, et al. 12. Antibacterial Synergy in Rubricine: Extract from the Root of Arnebia euchroma a Chinese Medicinal Herb; S. A. Benson, et al. 13. On the Quality Assessment of Chinese Patent Medicine; Peishan Xie, Yuzhen Yan. 14. Modernization of Traditional Chinese Medicine Needs Five Finger Mountain and Golden Head Ring; P. Pui-Hay But. 15. A Practical Comprehensive Approach to Chinese Medicine Research; P. C. Leung, K. P. Fung. 16. Back to Nature: The Alternative Paradigm for Drug Development; J. S. Bindra, et al. 17. Global Markets for Botanical Products; P. Brevoort. 18. Opportunities and Challenges of Developing Medicinal Herbs; M. Chang. 19. Traditional Chinese Medicines: Regulatory and Scientific Challenges; M. Edgar. 20. Marco Polo Technologies: A Model for a Modern TCM Company; R. Yuan. 21. Commercialization of Chinese Herbal Medicine in the Global Market; Chung Guang Shen. 22. The Development of Modern TCM in China Tianfa Group; Jialong Gong. FDA Forum; Yuan Yuan Chiu, et al. Program. Invited Speakers. Subject Index. Publisher Marketing: The "First International Conference on Traditional Chinese Medicine: Science, Regulation and Globalization" was held from August 30 to September 2, 2000 at the University of Maryland at College Park, Maryland. There were approximately 250 participants from the Peoples Republic of China, Taiwan, Hong Kong and the United States. This objective of this conference was to promote international collaboration for the modernization of Traditional Chinese herbal medicines (TCM) and their introduction into the global health care system. It was mainly sponsored by the Ministry of Science and Technology of the People's Republic of China and the NllI National Center for Complementary and Alternative Medicine (NCCAM). It was organized by Dr. William Tai, then director of the Institute of Global Chinese Affairs at the University of Maryland and Dr. Yuan Lin, president of Marco Polo Technologies, Bethesda, MD. This conference was conceived by Dr. Tai two years earlier recognizing that this was an appropriate time and also the unique location of the University of Maryland. Today, there is a growing recognition of the of alternative medicine in modem societies and the rapid loss of importance knowledge about traditional methods for the treatment of the multitude of human illnesses found throughout the world. TCM has been in common use in China for thousands of years; and many of its formulations are well defined.